This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bachelot, A. Articles by Touraine, P. Search for Related Content PubMed PubMed Citation Articles by Bachelot, A. Articles by Touraine, P. Related Collections Female Endocrinology

Ovarian Steroidogenesis and Serum Androgen Levels in Patients with Premature Ovarian Failure

Department of Endocrinology and Reproductive Medicine (A.B., N.M., F.K., P.T.), Hôpital Necker, 75743 Paris, France; Unité de Recherche (G.M.), Institut National de la Santé et de la Recherche Médicale, Unité 135, Hormones, Genes and Reproduction; and Unité de Recherche (M.M.), Institut National de la Santé et de la Recherche Médicale, Unité 120, Hôpital Bicêtre, 94275 Le Kremlin Bicêtre, France

Address all correspondence and requests for reprints to: Dr. Philippe Touraine, Department of Endocrinology and Reproductive Medicine, Hôpital Necker, 149 rue de Sèvres, Paris Cedex 15, 75743, France. E-mail: philippe.touraine{at}nck.ap-hop-paris.fr.

Women with premature ovarian failure (POF) have been reported to have lower serum androgen levels compared with normal women. We reviewed the androgen profiles of 143 POF patients and found androgen levels above normal for postmenopausal women in 16% of these subjects. To determine the source of androgens in those women, we studied the available ovarian biopsy samples of 15 POF patients with increased androgen levels using immunohistochemistry, with a panel of antibodies directed against the main steroidogenic enzymes. Five of the ovarian biopsies exhibited abnormal follicles characterized by hypertrophied theca interna expressing steroidogenic enzymes involved in androgen synthesis. In five other biopsies, the steroidogenic activity was scarce and confined to a small number of ovarian stromal cells, sometimes situated in the proximity of follicular remnants. Finally, in five patients, we found no histological evidence of present or past follicular development beyond the quiescent follicular stage, and no steroidogenic cells were detected by immunohistochemistry. Our findings suggest that ovarian theca-derived cells are a source of androgens in some women with POF, whereas in others, as in most postmenopausal patients, the adrenals or the ovarian hilus cells may synthesize a significant quantity of androgens under LH stimulation.

This article has been cited by other articles:

				A. Bachelot, A. Rouxel, N. Massin, J. Dulon, C. Courtillot, C. Matuchansky, Y. Badachi, A. Fortin, B. Paniel, F. Lecuru, et al. Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure Eur. J. Endocrinol., July 1, 2009; 161(1): 179 - 187. [Abstract] [Full Text] [PDF]

				M. Alevizaki, K. Saltiki, E. Mantzou, E. Anastasiou, and I. Huhtaniemi The adrenal gland may be a target of LH action in postmenopausal women. Eur. J. Endocrinol., June 1, 2006; 154(6): 875 - 881. [Abstract] [Full Text] [PDF]

				K. Saner-Amigh, B. A. Mayhew, F. Mantero, F. Schiavi, P. C. White, C. V. Rao, and W. E. Rainey Elevated Expression of Luteinizing Hormone Receptor in Aldosterone-Producing Adenomas J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1136 - 1142. [Abstract] [Full Text] [PDF]

				W. Arlt Androgen therapy in women Eur. J. Endocrinol., January 1, 2006; 154(1): 1 - 11. [Abstract] [Full Text] [PDF]